Terms ending in 2027
Every in-force patent on Genentech, Inc.'s record whose computed term ends in 2027, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 7,476,724 | Humanized Anti-Cmet Antibodies In force · High confidence | Genentech, Inc. | In force | High confidence | |
| US 9,186,293 | Vision Measurement and Training System and Method of Operation Thereof In force · High confidence | Genentech, Inc. | In force | High confidence | |
| US 10,179,081 | Vision Measurement and Training System and Method of Operation Thereof In force · High confidence | Genentech, Inc. | In force | High confidence | |
| US 9,675,707 | ANTI-TAT226 Antibodies and Immunoconjugates In force · Medium confidence | Genentech, Inc. | In force | Medium confidence | |
| US 8,450,315 | Phosphoinositide 3-Kinase Inhibitor Compounds and Methods of Use In force · Medium confidence | Genentech, Inc. | In force | Medium confidence | |
| US 9,139,878 | Methods for Diagnosing and Treating Systemic Lupus Erythematosus In force · Medium confidence | Genentech, Inc | In force | Medium confidence | |
| US 9,487,578 | Methods and Compositions for Targeting Polyubiquitin In force · Medium confidence | Genentech, Inc. | In force | Medium confidence | |
| US 8,029,783 | DR5 Antibodies and Articles of Manufacture Containing Same In force · High confidence | Genentech, Inc. | In force | High confidence | |
| US 7,803,377 | ANTI-DLL4 Antibodies and Methods Using Same In force · High confidence | Genentech, Inc. | In force | High confidence | |
| US 12,371,510 | Process for Concentration of Antibodies and Therapeutic Products Thereof In force · Medium confidence | Genentech, Inc. | In force | Medium confidence | |
| 13 more term ends in 2027 · Pro | |||||
10 of 23 patents shown. Soonest term end first, then patent number.
Pro members see all 23, all of them expiring within the 18 months from Nov 18, 2026.
22 of these are in force and held by Genentech, Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.